Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
Capsaicin, the active ingredient found in red-hot peppers, is used mainly for the relief of chronic pain of rheumatoid arthritis and osteoarthritis More
FMC Pharma is devoted to the treatment of osteoarthritis through the development of products, marketing methodologies and out-licensing opportunities. More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
Suite of proprietary collagen-binding peptides derived from bone sialoprotein (BSP) that are effective in promoting bone repair and regeneration. More
Identification and use of RAR antagonists to induce bone and cartilage formation More
A highly versatile spinal fixation system designed to treat all types of pathologies affecting the spine (ie resulting from degenerative problems, trauma, infections, tumours and general spinal deformities) More
Hyaluronan based gel for prevention and reduction of adhesion formation in tendon and nerve surgery More
In-home device to induce cycling motion in patients who have little or no motor control of their legs - increasing muscle mass and decreasing hyperreflexia More
Discloses the Promoter Sequence of Human Myo-D1 Gene and its Methylation Alteration in Tumorigenesis and Normal Development More
Displaying 1..10 of 10 - per page
Order by

Your selection

Therapeutic target
Musculoskeletal del
Musculoskeletal disorder (other) del

Browse By

Partnering consultation free of charge
EuroPLX 38 + 39
FDA/CMS Summit
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us